BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

Pharvaris NV (NASDAQ:PHVS)

2 posts

Biotech NewsPharvaris (PHVS): The $300M Biotech that Could Be the Next Big Thing in Pharma

  • BioTech Health X
  • July 18, 2025
Pharvaris N.V. is a clinical-stage biopharmaceutical company dedicated to developing novel oral therapies for patients suffering from hereditary…
0 Shares
0
0
0
0
0
0
0

Biotech NewsWall Street’s Best-Kept Biotech Secret? Why Pharvaris (PHVS) Could Be the Next $3 Billion Breakout

  • BioTech Health X
  • July 4, 2025
Pharvaris NV is a clinical-stage biopharmaceutical company headquartered in Leiden, the Netherlands, that is redefining the future of…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • Vor Biopharma (VOR) Could Be the Most Undervalued Biotech of the Year
  • 180 Life Sciences (ATNF) Just Raised $425 Million—And It’s Not Just a Biotech Anymore
  • Editas Medicine (EDIT)’s $178 Million War Chest: The CRISPR Comeback Investors Can’t Ignore
  • Generation Bio (GBIO)’s $100MCash Lifeline: Is a Massive Comeback on the Horizon?
  • Titan Pharma (TTNP): This Tiny Drugmaker Is Taking on Big Pharma — And Could Win!
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • August 13, 2025
    Vor Biopharma (VOR) Could Be the Most Undervalued Biotech of the Year
    • August 13, 2025
    180 Life Sciences (ATNF) Just Raised $425 Million—And It’s Not Just a Biotech Anymore
    • August 13, 2025
    Editas Medicine (EDIT)’s $178 Million War Chest: The CRISPR Comeback Investors Can’t Ignore
    • August 13, 2025
    Generation Bio (GBIO)’s $100MCash Lifeline: Is a Massive Comeback on the Horizon?
    • August 12, 2025
    Titan Pharma (TTNP): This Tiny Drugmaker Is Taking on Big Pharma — And Could Win!
Recent Posts
  • Health In Tech (HIT) is Making Healthcare Affordable and Scalable for Businesses
    • August 12, 2025
  • Here’s Why Wall Street Is Suddenly Obsessed with ImmunityBio (IBRX)
    • August 12, 2025
  • BioXcel (BTAI)’s BXCL501 Could Be the Game Changer in Treating Agitation Disorders
    • August 12, 2025
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (1)
  • Biotech News (307)
  • Uncategorized (1)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top